Combining Immune Checkpoint Inhibitors Ups Risk of Endocrine Dysfunction Combining Immune Checkpoint Inhibitors Ups Risk of Endocrine Dysfunction
Cancer patients taking a combination of PD-1 and CTLA-4 inhibitors are at increased risk of thyroid dysfunction and hypophysitis, a meta-analytic review has found.Reuters Health Information
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Hematology-Oncology News Source Type: news
More News: Allergy | Allergy & Immunology | Cancer | Cancer & Oncology | Hematology | Thyroid | Thyroid Cancer